Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients

Blood

Volumn 87, Issue 1, 1996, Pages 386-392

  Deeg, H J ^a   Socie G ^b   Schoch, G ^b   Henry Amar, M ^b   Witherspoon, R P ^b   Devergie, A ^b   Sullivan, K M ^b   Gluckman, E ^b   Storb, R ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CANCER RISK; CLINICAL ARTICLE; DOSE CALCULATION; FANCONI ANEMIA; FEMALE; GENDER; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SECOND CANCER; SOLID TUMOR; WHOLE BODY RADIATION;

EID: 0030052691     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.386.bloodjournal871386     Document Type: Article

References (49)

1. Boice JD: Cancer following medical irradiation. Cancer 47:1081, 1981
2. Hawkins MM, Draper GJ, Kingston JE: Incidence of secondary primary tumours among childhood cancer survivors. Br J Cancer 56:339, 1987
3. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76, 1988
4. Eguiguren JM, Ribeiro RC, Pui CH, Hancock ML, Pratt CB, Head DR, Crist WM: Secondary non-Hodgkin's lymphoma after treatment for childhood cancer. Leukemia 5:908, 1991
5. Younus J, Ahmed AR: Autoimmunity and malignancy. J Am Acad Dermatol 23:720, 1990
6. Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E: Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 329:1152, 1993
7. Socié G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E: Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 78:277, 1991
8. Deeg HJ, Witherspoon RP: Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am 7:417, 1993
9. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb R, Thomas ED: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:784, 1989
10. Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H: Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 12:2187, 1994
11. Witherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM: Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone Blood 79:289, 1992 (letter)
12. Kolb HJ, Bender-Götze C: Late complications after allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 6:61, 1990
13. Kolb HJ, Guenther W, Duell T, Socie G, Schaeffer E, Holler E, Schumm M, Horowitz MM, Gale RP, Fliedner TM: Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. Bone Marrow Transplant 10:135, 1992 (suppl 1)
14. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovich AH: Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234, 1988
15. Tichelli A, Gratwohl A, Nissen C, Speck B: Late clonal complications in severe aplastic anemia. Leuk Lymph 12:167, 1994
16. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K, Hansen H, Martin P, Pepe M, Sale G, Sanders J, Singer J, Sullivan KM, Thomas ED, Witherspoon RP: Cyclophosphamide combined with antithymocyte globuline in preparatin for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941, 1994
17. Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice RL, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP: Marrow transplantation for aplastic anemia. Semin Hematol 21:27, 1984
18. Gluckman E, Devergie A, Meletis J, Traineau R, Vilmer E, Lehn E, Keable H, Bourrhis JH, Varrin F: Bone marrow transplantation in severe aplastic anaemia. Report of 97 consecutive patients. Bone Marrow Transplant 2:101, 1987
19. Gluckman E, Socie G, Devergie A, Bourdeau-Esperou H, Traineau R, Cosset JM: Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: Long-term follow-up. Blood 78:2451, 1991
20. Socie G, Henry-Amar M, Devergie A, Wibault P, Neiger M, Cosset JM, Gluckman E. Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leuk Lymph 7:419, 1992
21. Flowers MED, Doney KC, Storb R, Deeg HJ, Sanders JE, Sullivan KM, Bryant E, Witherspoon RP, Appelbaum FR, Buckner CD, Hansen JA, Thomas ED: Marrow transplantation for Fanconi anemia with or without leukemic transformation: An update of the Seattle experience. Bone Marrow Transplant 9:167, 1992
22. Gluckman E, Hows J: Bone marrow transplantation in Fanconi's anemia, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, p 902
23. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
24. Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, Deeg HJ, Sanders JE, Doney KC, Appelbaum FR, McGuffin R, McDonald GB, Meyers J, Schubert MM, Gauvreau J, Shulman HM, Sale GE, Anasetti C, Loughran TP, Strom S, Nims J, Thomas ED: Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 72:546, 1988
25. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
26. Muir C, Waterhouse J, Mack T: Cancer Incidence in Five Continents, Vol V, World Health Organization, IARC Scientific Publications No. 88. Lyon, France, International Agency for Research on Cancer, 1987
27. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
28. Cox DR: Regression models and life-tables (with discussions), series B. J Roy Statist Soc 34:187, 1972
29. SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, Release 6.07. Cary, NC, SAS Institute, Inc., 1992
30. Fischer A, Friedrich W, Fasth A, Blanche S, Le Deist F, Girault D, Veber F, Vossen J, Lopez M, Griscelli C, Him M: Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: A European Group for Immunodeficiency/European Group for Bone Marrow Transplantation Report. Blood 77:249, 1991
31. Schubach WH, Hackman R, Neiman PE, Miller G, Thomas ED: A monocional immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood 60:180, 1982
32. Zutter MM, Durnam DM, Hackman RC, Loughran TP Jr, Kidd PG, Ashley RL, Petersdorf EW, Martin PJ, Thomas ED: Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol 94:714, 1990
33. Skinner JC, Gilbert EF, Hong R: B cell lymphoproliferative disorders following T cell depleted allogeneic bone marrow transplantation. Am J Ped Hematol Oncol 10.112, 1988
34. Breatnach F, Chessells JM, Greaves MF: The aplastic presentation of childhood leukaemia: A feature of common ALL. Br J Haematol 49:387, 1981
35. Klingemann H-G, Storb R, Sanders J, Deeg HJ, Appelbaum FR, Thomas ED: Acute lymphobiastic leukaemia after bone marrow transplantation for aplastic anaemia. Br J Haematol 63:47, 1986
36. Young NS, Alter BP: Clinical features of Fanconi's anemia. Chapter 14, in Aplastic Anemia Acquired and Inherited. Philadelphia. PA, Saunders, 1994, p 275
37. Reed K, Ravikumar TS, Gifford RR, Grage TB: The association of Fanconi's anemia and squamous cell carcinoma. Cancer 52:926, 1983
38. Alter BP: Constitutional aplastic anemia, in Shahidi NT (ed): Aplastic Anemia and Other Bone Marrow Failure Syndromes. New York, NY, Springer-Verlag, 1990, p 38
39. Kennedy AW, Hart WP: Multiple squamous-cell carcinomas in Fanconi's anemia. Cancer 50:811, 1982
40. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD: Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry study. Blood 84:1650, 1994
41. Terzaghi M, Little JB: Repair of potentially lethal radiation damage in mammalian cells is associated with enhancement of malignant transformation. Nature 253:548, 1975
42. Deeg HJ, Storb R, Thomas ED, Appelbaum F, Buckner CD, Chft RA, Doney K, Johnson L, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP: Fanconi's anemia treated by allogeneic marrow transplantation. Blood 61:954, 1983
43. Hows JM, Chapple M, Marsh JCW, Durrant S, Yin JL, Swirsky D, Gordon-Smith EC: Bone marrow transplantation for Fanconi's anaemia: The Hammersmith experience 1977-89. Bone Marrow Transplant 4:629, 1989
44. Kohil-Kumar M, Morris C, DeLaat C, Sambrano J, Masterson M, Mueller R, Shahidi NT, Yanik G, Desantes K, Friedman DJ, Auerbach AD, Harris RE. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 84:2050, 1994
45. Penn I: Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 7:431, 1993
46. Deeg HJ, Storb R, Prentice R, Fritz TE, Weiden PL, Sale GE, Graham TC, Thomas ED: Increased cancer risk in canine radiation chimeras. Blood 55:233, 1980
47. Deeg HJ, Prentice R, Fritz TE, Sale GE, Lombard LS, Thomas ED, Storb R: Increased incidence of malignant tumors in dogs after total body irradiation and marrow transplantation. Int J Radiat Oncol Biol Phys 9:1505, 1983
48. Leslie CA, Dubey DP: Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity? Prostaglandins 47:41, 1994
49. Styrt B, Sugarman B: Estrogons and infection. Rev Infect Dis 13:1139, 1991